| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.6 | 0.02 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |